Skip to content

Do patients with haemophilia differ from the general population regarding sports activity and injuries?

Sports Participation and Injuries in Patients with Haemophilia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25301
Enrollment
600
Registered
2017-10-24
Start date
2017-11-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia, sports participation, sports injuries, factor consumption, physical activity

Interventions

This study consists of a cross-sectional baseline study in which sports participation and perceived limitations are studied. Based on the outcomes of these questionnaires, participants will be select

Sponsors

University Medical Center Utrecht, Van Creveldkliniek
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with haemophilia A or B (FVIII/IX levels 0-30%), aged 6-65 years, treated at the Van Creveldkliniek.

Exclusion criteria

Exclusion criteria: - Refusal to participate or provide informed consent; - Presence of inhibitory antibodies against FVIII or FIX; - Recent surgery: arthroplasty or arthrodesis within the last 12 months.

Design outcomes

Primary

MeasureTime frame
- To quantify physical activity (PA), sports participation and exposure according to age, haemophilia severity and joint status; - To assess the incidence of sports-related injuries in those who participate in sports at least once every week; - To compare the incidence of sports-related injuries to the general male population. - To assess the association of sports-related injuries with physical fitness and motor proficiency.

Secondary

MeasureTime frame
To assess/model the effect of FVIII/IX activity at the time of bleeding due to sports injuries, independent of age, presence of arthropathy, motor proficiency and physical fitness.

Contacts

Public ContactOlav Versloot

Van Creveldkliniek, Huispost C01.425

o.versloot@umcutrecht.nl+31 88 7569305

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)